Capstone Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Capstone Capital Management's BMY Position: Q2 2026 in Review
Capstone Capital Management increased its Bristol-Myers Squibb (BMY) stake by 91% in Q2 2026, buying an estimated $386K and bringing the position to 14,109 shares worth $813K. The position accounts for 0.36% of the portfolio, ranked #79.
Capstone Capital Management first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. 2,511 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Capstone Capital Management held 14,109 shares of Bristol-Myers Squibb worth $813K as of Q2 2026.
- Capstone Capital Management bought 6,729 Bristol-Myers Squibb shares in Q2 2026, an estimated $386K.
- Bristol-Myers Squibb made up 0.36% of Capstone Capital Management's portfolio in Q2 2026, its #79 holding.
- Capstone Capital Management first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
- 2,511 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Capstone Capital Management's 13F filing for Q2 2026, filed 20 Jul 2026.